approval
savePRIFTIN (RIFAPENTINE) — FDA approval
community read0 votes
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalPRIFTIN (RIFAPENTINE) — FDA approvalJun 9, 2020 · 2307d ago
- approvalPRIFTIN (RIFAPENTINE) — FDA approvalJun 5, 2020 · 2311d ago
- approvalPRIFTIN (RIFAPENTINE) — FDA approvalJun 5, 2020 · 2311d ago
- approvalPRIFTIN (RIFAPENTINE) — FDA approvalAug 7, 2015 · 4075d ago
- approvalPRIFTIN (RIFAPENTINE) — FDA approvalJul 1, 2015 · 4112d ago
- approvalPRIFTIN (RIFAPENTINE) — FDA approvalNov 25, 2014 · 4330d ago
- approvalPRIFTIN (RIFAPENTINE) — FDA approvalNov 20, 2014 · 4335d ago
- approvalPRIFTIN (RIFAPENTINE) — FDA approvalJul 30, 2010 · 5909d ago
same company · ±60 days · 6
- approvalprimaquine phosphate: PRIMAQUINE (PRIMAQUINE PHOSPHATE) — FDA approvalFeb 2, 2026
- approvalteriflunomide: AUBAGIO (TERIFLUNOMIDE) — FDA approvalFeb 11, 2026
- approvalToujeo LA: SOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalMar 12, 2026
- approvalADLYXIN: ADLYXIN (LIXISENATIDE) — FDA approvalMar 12, 2026
- approvalRIFATER: RIFATER (ISONIAZID) — FDA approvalDec 5, 2025
- approvalRIFADIN: RIFADIN (RIFAMPIN) — FDA approvalDec 5, 2025
comments(0)
5-min edit window · permanent after that